InvestSMART

Golden parachute for CSL's boss

The long-serving chief executive of blood products and vaccine supplier CSL will take home $4.9 million in one-off payments when he severs ties with the company in October.
By · 29 Jun 2013
By ·
29 Jun 2013
comments Comments
The long-serving chief executive of blood products and vaccine supplier CSL will take home $4.9 million in one-off payments when he severs ties with the company in October.

Brian McNamee could also be awarded shares worth about $18 million in coming years under long-term incentive plans.

Dr McNamee's 23-year career as chief executive of CSL ended on Friday, and his contract with the company expires on October 15.

Under his leadership, CSL has grown from a small government enterprise to a listed company worth more than $30 billion.

Dr McNamee will be paid a $2.8 million severance payment as well as $2.1 million for nearly 200 days of untaken annual leave and sick leave.

He is also entitled to almost 125,500 performance rights and more than 179,000 performance options as part of long-term incentives, worth about $18 million.
Google News
Follow us on Google News
Go to Google News, then click "Follow" button to add us.
Share this article and show your support
Free Membership
Free Membership
InvestSMART
InvestSMART
Keep on reading more articles from InvestSMART. See more articles
Join the conversation
Join the conversation...
There are comments posted so far. Join the conversation, please login or Sign up.

Frequently Asked Questions about this Article…

The article names Brian McNamee (also referred to as Dr McNamee) as the long-serving chief executive of CSL. His 23-year career as CEO ended on Friday, and his contract with the company expires on October 15, when he will sever ties with CSL in October.

On departure the CEO will receive $4.9 million in one-off payments, made up of a $2.8 million severance payment and $2.1 million to cover nearly 200 days of untaken annual leave and sick leave.

The CEO is entitled to almost 125,500 performance rights and more than 179,000 performance options as part of long-term incentive plans. Those LTI awards are estimated to be worth about $18 million in coming years.

He served as CSL's chief executive for 23 years. Under his leadership CSL grew from a small government enterprise into a listed company worth more than $30 billion, according to the article.

The $2.1 million payment covers nearly 200 days of untaken annual leave and sick leave that the CEO had accrued prior to his departure.

The article states that his contract with CSL expires on October 15.

He is entitled to almost 125,500 performance rights and more than 179,000 performance options as part of the company's long-term incentive plans.

Key facts from the article: the long-serving CSL CEO is leaving with $4.9 million in one-off payments (a $2.8 million severance plus $2.1 million for nearly 200 days of untaken leave); he may also receive LTI awards (about 125,500 performance rights and over 179,000 performance options) worth roughly $18 million in future years; his 23-year tenure has seen CSL grow to a listed company valued at more than $30 billion; his contract expires on October 15.